Apparently, no statistically sizeable difference was noticed amongst the 84 mg intranasal esketamine moreover oral antidepressant dose as well as the placebo nasal spray moreover oral antidepressant. However, because the predefined testing sequence constrained testing of review endpoints involving fifty six mg intranasal esketamine furthermore or